← SynDRA
CFM-2
SynDRA canonical compound SYN0078837 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | glutamate receptor antagonist |
|---|
Mechanisms of action (all sources)
- glutamate receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ALOX15
- CYP3A4
- GPR68
- HDAC6
- HPGD
- HSD17B10
- KDM4E
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- RefChem:333641
- DTXCID40353446
- NCGC00024988-01
- Tocris-1082
- Biomol-NT_000179
- BPBio1_001170
- orb1710082
- SCHEMBL1056361
- SCHEMBL29651353
- CHEBI:107638
- GLXC-01807
- HMS3267G18
- HMS3412G05
- HMS3676G05
- EX-A14447
- HB0179
- MFCD01321072
- AKOS024456374
- CS-3625
- NCGC00024988-02
- HY-12503
- MS-24535
- E98695
- T10774
- SR-01000597376
- SR-01000597376-1
- BRD-K42859542-001-01-7
- BRD-K42859542-001-02-5
- BRD-K42859542-001-03-3
- 1-(4-aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one
Look up CFM-2 in the interactive SynDRA portal →